The association between plasma complement C3 levels and coronary heart disease (CHD) within the context of smoking behavior was examined in the CODAM (Cohort on Diabetes and Atherosclerosis Maastricht; sample size n= 562) study (48). Here, C3 is linked to coronary artery disorder.